Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides
Video · 25 min · Captions · Sep 29, 2022
Benjamin Prosser, University of Pennsylvania Perelman School of Medicine, PhD
Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
Pharmacology, Biotechnology, Molecular Biology and seminar by Annemieke Aartsma-Rus, Leiden University Medical Center, the Netherlands
Hosted by ERN-RND
Tuesday 17:00–18:10 Paris (GMT+2)
Recording available
Online
Related seminars
More from ERN-RND
All talksClinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
Video page · Sep 27, 2022Daniel WeißImportance of autopsies in leukodystrophies
Video page · Jul 12, 2022Marianna BugianiBiofluid biomarkers in atypical parkinsonism
Video page · Jun 21, 2022Per SvenningssonMitochondrial leukodystrophies
Video page · May 24, 2022Anna Ardissone
More with Annemieke Aartsma-Rus
All their workAntisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide
Seminar · Video page · Mar 29, 2022ERN-RND